Effect of Estrogen on Heteronemin-Induced Anti-proliferative Effect in Breast Cancer Cells With Different Estrogen Receptor Status.
anti-proliferation
breast cancer
estrogen
estrogen receptor status
heteronemin
mitochondrial ROS
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
04
2021
accepted:
02
07
2021
entrez:
12
8
2021
pubmed:
13
8
2021
medline:
13
8
2021
Statut:
epublish
Résumé
Estrogen (E
Identifiants
pubmed: 34381775
doi: 10.3389/fcell.2021.688607
pmc: PMC8350732
doi:
Types de publication
Journal Article
Langues
eng
Pagination
688607Informations de copyright
Copyright © 2021 Yang, Li, Huang, Su, Lin, Huang, Chen, Lu, Huang, Lee, Whang-Peng, Lin, Davis and Wang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Oxid Med Cell Longev. 2018 Apr 26;2018:2138502
pubmed: 29854077
Horm Cancer. 2018 Oct;9(5):349-360
pubmed: 30027502
J Agric Food Chem. 2008 Feb 13;56(3):875-83
pubmed: 18189352
J Steroid Biochem Mol Biol. 2010 Oct;122(4):287-94
pubmed: 20478382
Front Endocrinol (Lausanne). 2019 Mar 12;10:130
pubmed: 30915033
Mol Aspects Med. 2014 Apr;36:1-55
pubmed: 23994691
Cancer Res. 2002 Feb 15;62(4):972-6
pubmed: 11861366
Carcinogenesis. 2001 Sep;22(9):1573-6
pubmed: 11532882
Cancer Res. 1994 Mar 1;54(5):1169-74
pubmed: 8118801
Oncotarget. 2018 Apr 6;9(26):18115-18127
pubmed: 29719594
Biomed Res Int. 2015;2015:738241
pubmed: 26090440
Oxid Med Cell Longev. 2019 May 7;2019:6342104
pubmed: 31205586
Biomed Pharmacother. 2015 Aug;74:101-10
pubmed: 26349970
Mol Med Rep. 2019 Apr;19(4):3353-3360
pubmed: 30816513
Nature. 2016 Apr 7;532(7597):112-6
pubmed: 27027295
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42
pubmed: 9380738
Breast Cancer Res. 2016 Sep 23;18(1):95
pubmed: 27663795
Biol Res. 2019 Mar 27;52(1):15
pubmed: 30917872
Free Radic Biol Med. 2010 Feb 15;48(4):506-12
pubmed: 19969066
Arch Toxicol. 2013 Oct;87(10):1851-61
pubmed: 23543012
J Agric Food Chem. 2009 Jun 24;57(12):5235-43
pubmed: 19441815
Steroids. 2007 Feb;72(2):165-70
pubmed: 17166537
Carcinogenesis. 2011 Aug;32(8):1285-93
pubmed: 21665890
Mar Drugs. 2018 Jun 10;16(6):
pubmed: 29890785
Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R612-8
pubmed: 15142837
J Clin Endocrinol Metab. 1999 Dec;84(12):4559-65
pubmed: 10599719
Reprod Biol Endocrinol. 2015 Mar 24;13:21
pubmed: 25889012
Oxid Med Cell Longev. 2017;2017:7348372
pubmed: 29163755
Mar Drugs. 2018 Dec 06;16(12):
pubmed: 30563284
Carcinogenesis. 2000 May;21(5):871-9
pubmed: 10783306
Mar Drugs. 2018 Jun 17;16(6):
pubmed: 29914195
Mar Drugs. 2020 Jul 02;18(7):
pubmed: 32630719
Redox Biol. 2015;4:184-92
pubmed: 25590798
Tumour Biol. 2016 Jan;37(1):141-50
pubmed: 26566628
PLoS One. 2013;8(2):e54206
pubmed: 23437041
Int J Mol Med. 2018 Sep;42(3):1427-1435
pubmed: 29916532
Oxid Med Cell Longev. 2021 Jan 4;2021:7689045
pubmed: 33488943
J Biol Chem. 2009 Nov 27;284(48):33456-65
pubmed: 19833733
Prostate. 2016 Dec;76(16):1469-1483
pubmed: 27416770
Mol Endocrinol. 2008 May;22(5):1113-24
pubmed: 18258688
BMC Med. 2015 Aug 17;13:195
pubmed: 26278220
Horm Cancer. 2018 Jun;9(3):156-165
pubmed: 29380230
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Science. 2004 Feb 13;303(5660):1010-4
pubmed: 14963330
Redox Biol. 2018 Sep;18:104-113
pubmed: 30007886
Oncotarget. 2015 Dec 29;6(42):44832-48
pubmed: 26540567
Cancer Lett. 2009 Nov 1;284(2):229-37
pubmed: 19457606
Oncogene. 2008 Jan 24;27(5):614-28
pubmed: 17637750
Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):940-950
pubmed: 29859845
Biochem Pharmacol. 2010 Feb 15;79(4):610-22
pubmed: 19814997